迈维宁
首页
关于迈维宁®
产品说明书
患者家园
医学信息
  • 首页
  • 关于迈维宁®
  • 产品说明书
  • 患者家园
  • 医学信息

Pharmacokinetics of High-Dose Propylene Glycol–Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

2024/01/02

下一页: Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation 上一页: Pharmacokinetics Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (

热门 文献

  • Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma 2024/01/02
  • Osmol Gap as a Surrogate Marker for Serum Propylene Glycol Concentrations in Patients Receiving Lorazepam for Sedation 2024/01/02
  • Stability of Melphalan in 0.9 % Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection 2024/01/02
  • Pharmacokinetics of High-Dose Propylene Glycol–Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation 2024/01/02
  • Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam 2024/01/02
关于迈维宁®
产品说明书
患者家园
医学信息
科普知识
Copyright © 2024 CASI Pharmaceuticals Inc. 版权所有